Wall Street Stands Firm on META With Buy Ratings After Shares Sink 7%

By TrendSpider Editor

Meta Platforms drew a wave of analyst reaffirmations on Thursday as 12 firms weighed in following a sharp 7.03% decline, with shares falling to $648.50. The highest price target in the batch came from Pivotal Research at $960, while the average across all 12 actions sits at $867.27, implying substan

Wall Street Stands Firm on META With Buy Ratings After Shares Sink 7%

Meta Platforms drew a wave of analyst reaffirmations on Thursday as 12 firms weighed in following a sharp 7.03% decline, with shares falling to $648.50. The highest price target in the batch came from Pivotal Research at $960, while the average across all 12 actions sits at $867.27, implying substantial upside from current levels. META's drop puts it well off its 52-week high of $779.82, though it remains above the 52-week low of $520.26.

Key Drivers of the META Stock Move

• Main Catalyst: Twelve analyst firms confirmed their existing ratings on META following today's selloff. Ten firms reiterated a "buy" rating and two firms maintained "hold." There were zero upgrades and zero downgrades among the 12 total actions.
• Bull Case: JP Morgan raised its price target to $940 from $920, Pivotal Research lifted its target to $960 from $930, and Susquehanna made the most aggressive revision, jumping its target to $850 from $650. Rosenblatt, Keybanc, Bank of America, and Cantor Fitzgerald also nudged targets higher, reflecting broad confidence in the fundamental story even amid the price weakness.
• Bear Case: Three firms trimmed their price targets. TD Cowen cut its target to $850 from $865, and Piper Sandler reduced its target to $850 from $875. The two "hold" ratings from StoneX and Wedbush, combined with those target reductions, suggest not every analyst views the dip as a clear buying opportunity. At $648.50, the stock now trades roughly 11% below even Wedbush's more cautious $730 target.

The forward setup for META is a tug-of-war between a deeply discounted price relative to analyst targets and whatever catalyst drove today's 7% selloff. With the average price target at $867.27 and the current price at $648.50, the implied upside across the analyst community is roughly in line with the upper half of META's 52-week range. The unanimity of the "buy" confirmations suggests the Street views today's weakness as event-driven rather than a fundamental deterioration. Whether the stock can recover will depend on how investors interpret the underlying trigger for the move and whether sentiment stabilizes heading into the next earnings cycle.

META Analyst Ratings and Price Targets

All 12 actions confirmed existing ratings with no upgrades or downgrades. The consensus skews heavily positive with 10 buys and 2 holds. The average price target across all 12 firms is $867.27.

• JP Morgan (Doug Anmuth): Confirms Buy | PT raised to $940 from $920
• TD Cowen (John Blackledge): Confirms Buy | PT lowered to $850 from $865
• Piper Sandler (Thomas Champion): Confirms Buy | PT lowered to $850 from $875
• StoneX (Mark Zgutowicz): Confirms Hold | No price target listed
• Wedbush (Ygal Arounian): Confirms Hold | PT raised to $730 from $700
• Rosenblatt (Barton Crockett): Confirms Buy | PT raised to $900 from $886
• Guggenheim (Michael Morris): Confirms Buy | PT unchanged at $850
• Susquehanna (Shyam Patil): Confirms Buy | PT raised to $850 from $650
• Keybanc (Justin Patterson): Confirms Buy | PT raised to $905 from $900
• Bank of America (Justin Post): Confirms Buy | PT raised to $845 from $810
• Cantor Fitzgerald (Deepak Mathivanan): Confirms Buy | PT raised to $860 from $840
• Pivotal Research (Jeffrey Wlodarczak): Confirms Buy | PT raised to $960 from $930

META Seasonality

Late October historically marks the start of a seasonally strong stretch for large-cap technology stocks as third-quarter earnings results and forward guidance set the tone heading into year-end. A sharp single-session decline of this magnitude in the October timeframe has, in past cycles, sometimes presented mean-reversion opportunities for patient investors.

META Relative Performance

META's 7.03% single-session decline is a significant underperformance relative to broader large-cap and mega-cap technology benchmarks on the day. With the stock at $648.50, it sits roughly 16.8% below its 52-week high of $779.82 and approximately 24.5% above its 52-week low of $520.26, placing it in the lower half of its annual range at a time when analyst price targets point to materially higher levels.